RT Journal Article
SR Electronic
T1 Pretibial myxedema (elephantiasic form): treatment with cytotoxic therapy
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 183
OP 188
VO 50
IS 2
A1 C. William Hanke
A1 Wilma F. Bergfeld
A1 Marcelle N. Guirguis
A1 L. James Lewis
YR 1983
UL http://www.ccjm.org/content/50/2/183.abstract
AB One of the four major components of Graves’ disease, prétibial myxedema (PTM), occurs in approximately 0.5% to 4.3% of patients with ophthalmic goiter and is often seen following treatment of the goiter. An advanced case of elephantiasic PTM is reported.